Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (161-170 of 278) with videos related to

Pageof 28
Sort By:
Cancer|March 13, 2016
National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base studyBrandon A Mahal, Yu-Wei Chen, Jason A Efstathiou, et al.
The Journal of Urology|September 6, 2017
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder CancerAlejandro Sanchez, Matthew F Wszolek, Andrzej Niemierko, et al.
European Urology|November 22, 2011
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experienceJason A Efstathiou, Daphna Y Spiegel, William U Shipley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Cost implications and complications of overtreatment of low-risk prostate cancer in the United StatesAyal A Aizer, Xiangmei Gu, Ming-Hui Chen, et al.
European Urology|September 30, 2019
Quality Indicators for Bladder Cancer Services: A Collaborative ReviewJeffrey J Leow, James W F Catto, Jason A Efstathiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Establishing and Delivering Quality Radiation Therapy in Resource-Constrained Settings: The Story of BotswanaJason A Efstathiou, Magda Heunis, Talkmore Karumekayi, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09Anthony L Zietman, Kyounghwa Bae, Jerry D Slater, et al.
NPJ Precision Oncology|December 1, 2025
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapyDavid J Konieczkowski, Keisuke Otani, Zoe Guan, et al.
Urologic Oncology|May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapyRobert T Dess, Payal D Soni, William C Jackson, et al.
Pageof 28

Showing results (161-170 of 278) with videos related to

Sort By:
Pageof 28
Cancer|March 13, 2016
National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base studyBrandon A Mahal, Yu-Wei Chen, Jason A Efstathiou, et al.
The Journal of Urology|September 6, 2017
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder CancerAlejandro Sanchez, Matthew F Wszolek, Andrzej Niemierko, et al.
European Urology|November 22, 2011
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experienceJason A Efstathiou, Daphna Y Spiegel, William U Shipley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Cost implications and complications of overtreatment of low-risk prostate cancer in the United StatesAyal A Aizer, Xiangmei Gu, Ming-Hui Chen, et al.
European Urology|September 30, 2019
Quality Indicators for Bladder Cancer Services: A Collaborative ReviewJeffrey J Leow, James W F Catto, Jason A Efstathiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Establishing and Delivering Quality Radiation Therapy in Resource-Constrained Settings: The Story of BotswanaJason A Efstathiou, Magda Heunis, Talkmore Karumekayi, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09Anthony L Zietman, Kyounghwa Bae, Jerry D Slater, et al.
NPJ Precision Oncology|December 1, 2025
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapyDavid J Konieczkowski, Keisuke Otani, Zoe Guan, et al.
Urologic Oncology|May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapyRobert T Dess, Payal D Soni, William C Jackson, et al.
Pageof 28